Treatment for nonresectable hepatocellular carcinoma (HCC) is palliative. The relatively
greater arteriolar density of hepatic tumors compared with normal liver suggests that …

Purpose: To evaluate the efficacy of intraarterial 90yttrium (90Y) microspheres in
nonresectable hepatocellular carcinoma (HCC). Methods and Materials: Patients with …

PURPOSE: Intraarterial injection of yttrium 90 microspheres (TheraSpheres) is used in the
treatment of hepatocellular carcinoma (HCC). This article presents an analysis of the …

Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor
prognosis and limited treatment options. Most available therapies are used only for …

PURPOSE: To present the findings of a risk-stratification survival analysis with use of data
collected on a heterogeneous group of patients with hepatocellular carcinoma (HCC) …

PURPOSE: To present safety and efficacy results obtained in treatment of a cohort of
patients with unresectable hepatocellular carcinoma (HCC) with use of 90Y microspheres …

Purpose: To investigate the antitumor effect of resin microspheres loaded with 90-yttrium
against hepatocellular carcinoma and their safety in the setting of liver cirrhosis. Patients …

Methods. Ten patients with primary hepatocellular carcinoma were treated with intraarterial
instillation of yttrium‐90 (Y‐90) microspheres, including eight men and two women (median …

Background Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver
that most commonly presents late in the disease course. As a result, the majority of patients …

We present the correlation between radiologic and pathologic findings in HCC patients who
underwent radioembolization with yttrium‐90 (90Y) microspheres prior to resection or …